跳至主要内容
临床试验/DRKS00010278
DRKS00010278已完成未知

Effect of an oral nutritional supplement therapy on muscle mass, bone metabolism, body composition, growth, and disease activity in pediatric Crohn’s Disease: a controlled trial

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 42 人开始时间: 2016年4月18日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • Diagnosis of CD, age 6 – 18 y , in clinical remission or with mild disease activity (weighted PCDAI = 40), on stable medical treatment, signed consent form obtained by guardians and ascent of participants

排除标准

  • Patients will be excluded if they have undergone a major surgical resection of the small or large bowel (>20 cm), have cow’s milk protein allergy, have other chronic disease (liver, heart, renal etc.), have been treated with systemic corticosteroid, exclusive enteral nutrition, growth hormone or anabolic steroids in the last 3 months and/or require therapy intensification at the inclusion visit, or had bone density examination (DXA or pQCT) within 12 months prior to invitation to study participation.

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验